News
China rejected US trade overtures Thursday, demanding all tariffs be lifted and denying any progress in talks. "The US should ...
Merck on Thursday said its first-quarter adjusted profit rose 7% as lower costs helped offset a 2% decline in sales, ...
Germany's Merck KGaA is nearing a roughly $3.5 billion deal for SpringWorks Therapeutics , the Wall Street Journal reported ...
With potential tariffs and other drug pricing policies on the horizon, the industry is navigating uncertain waters. | The ...
Pharmaceuticals giant Merck & Company (MRK) has cut its full-year profit forecasts fearing a $200 million hit from President ...
Merck (MRK) stock trades flat as Halozyme Therapeutics (HALO) files patent infringement suit linked to MRK's new injectable ...
A biotech company is suing to block Merck & Co. from launching an easier-to-use version of its blockbuster cancer treatment ...
FY25 consensus $8.94. Backs FY25 revenue $64.1B-$65.6B, consensus $65.01B. Outlook Revised to Reflect Negative Impact From Anticipated One-Time Charge of Approximately 6c per Share Related to License ...
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
The pharmaceutical industry faces environmental challenges. Green chemistry offers sustainable solutions to reduce waste and ...
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results